Kevin Smidt, MD
Orthopaedic Surgery · Canal Winchester, OHNPI 1164929600
Payments from drug & device makers
What this record shows
The money is spread across several categories — food and beverage (32.8%), travel and lodging and grants — rather than concentrated in one kind of arrangement. 8 manufacturers reported payments, led by Smith+Nephew at 38.5% of the total. Reporting peaked in 2024 at $8,393 and has fallen 80.6% since, to $1,630 in 2025.
Across 112 payments — averaging $138.97 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Smith+Nephew$6K
- Stryker$5K
- Medacta USA, Inc.$4K
- Johnson & Johnson$590
- Think Surgical, Inc.$371
- Axogen$65
- plus $60 from 2 others
What the payments were for
- Grants$3,00019%
- Travel & lodging$4,45329%
- Food & beverage$5,11233%
- Education$3,00019%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Smith+Nephew | 2 | $6,000 |
| Stryker | 69 | $4,758 |
| Medacta USA, Inc. | 27 | $3,721 |
| Johnson & Johnson | 5 | $590 |
| Think Surgical, Inc. | 5 | $371 |
| Axogen | 2 | $65 |
| Midsouth Orthopedics Inc. | 1 | $40 |
| Vertex | 1 | $20 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- MAKO$2,620
- GMK Sphere Revision System$2,430
- GMK SPHERE$378
- SPHERIKA$331
- TMINI Miniature Robotic System$148
- ACTIS$146
- RIGIDLOOP$146
- VAPR$141
- TORNIER PERFORM ANATOMIC AUGMENTED GLENOID$112
- ORTHOLOC 2 LAPIFUSE$111
- INSIGNIA$105
How this compares
$15,565 in reported general payments places this provider in the 80th percentile of 794 orthopaedic surgery providers in Ohio.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Celecoxib | 88 | $1,133 |
| Oxycodone Hcl | 63 | $339 |
| Ondansetron OdtOndansetron | 56 | $305 |
| Pantoprazole Sodium | 44 | $230 |
| Meloxicam | 19 | $134 |
| Tramadol Hcl | 30 | $127 |
| Cefadroxil | 34 | $118 |
| Ondansetron Hcl | 12 | $62 |
Paid to pharmacies, not to this prescriber.
Other orthopaedic surgery in Canal Winchester
- Reuben GobezieCleveland$12M
- Gregory BerletWorthington$9.6M
- Wael BarsoumCleveland$8.9M
- Brian CohenChillicothe$8.8M
- Joseph IannottiCleveland$7.1M
- John SontichYoungstown$3.6M
- Anthony MiniaciCleveland$3.1M
- David WelkerMiamisburg$2.8M
- Kenneth GreeneCleveland$2.6M
- Mark FroimsonCleveland$2.5M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.